ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT07038096 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer
Neuroendocrine Carcinoma

Interventions

DRUG: ZG006
DRUG: ZG005

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd